JANSSEN PHARMACEUTICA
Date updated: 2026-04-19
TOTAL PRODUCT APPROVED: 2
Overview
Product Registered
Categories
Type of Products
Analysis
Product Holder
| Product holder name | Product count |
|---|---|
| 2 |
Product count2
Rows per page:
1–1 of 1
Analysis
Product API
| Ingredient (API) name | Product count |
|---|---|
| 2 |
Product count2
Rows per page:
1–1 of 1
Related Articles
An introduction to AIPharm - Making Good Pharmaceutical Data Accessible to Everyone
Manfye Goh · 2 min read
Bridging the Gap: Assessing Hypertension Drug Availability and Alignment with Malaysian CPG Guidelines and MOH Formulary
Manfye Goh · 12 min read
The 2022 New Health Supplement Products Analysis
Manfye Goh · 6 min read
Listing
Registered Product
| Product name | Product Reg. no | Type | Product Holder | Manufacturer | Importer | Registration Status |
|---|---|---|---|---|---|---|
| INVEGA HAFYERA 1000 mg/5.0 mL Prolonged-Release Suspension for Intramuscular Injection | MAL23126006AZ | NEW CHEMICAL ENTITY | JOHNSON & JOHNSON SDN. BHD. | JANSSEN PHARMACEUTICA | JOHNSON & JOHNSON SDN. BHD. | PRODUCT APPROVED |
| INVEGA HAFYERA 700 mg/3.5 mL Prolonged-Release Suspension for Intramuscular Injection | MAL23126007AZ | NEW CHEMICAL ENTITY | JOHNSON & JOHNSON SDN. BHD. | JANSSEN PHARMACEUTICA | JOHNSON & JOHNSON SDN. BHD. | PRODUCT APPROVED |
INVEGA HAFYERA 1000 mg/5.0 mL Prolonged-Release Suspension for Intramuscular Injection
Product Reg. noMAL23126006AZ
TypeNEW CHEMICAL ENTITY
Product HolderJOHNSON & JOHNSON SDN. BHD.
ManufacturerJANSSEN PHARMACEUTICA
ImporterJOHNSON & JOHNSON SDN. BHD.
Registration StatusPRODUCT APPROVED
INVEGA HAFYERA 700 mg/3.5 mL Prolonged-Release Suspension for Intramuscular Injection
Product Reg. noMAL23126007AZ
TypeNEW CHEMICAL ENTITY
Product HolderJOHNSON & JOHNSON SDN. BHD.
ManufacturerJANSSEN PHARMACEUTICA
ImporterJOHNSON & JOHNSON SDN. BHD.
Registration StatusPRODUCT APPROVED
Rows per page:
1–2 of 2